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Abstract 
Background 
Apoptosis is a programme of cell death which does not induce an inflammatory response. Recent 
previous research has suggested a correlation between temporomandibular internal derangement and 
apoptosis. Fas ligand (FasL) is an apoptosis-inducing factor, known to trigger apoptosis through distinct 
signal pathways. This study aims to examine, by immunohistochemistry, the expression of FasL in 
temporomandibular joint (TMJ) articular discs of patients with anterior disc displacement with reduction 
(ADDwR) and without reduction (ADDwoR) in patients with and without osteoarthrosis (OA). 
Methods 
Forty-two (n = 42) TMJ articular discs were divided into two cut-offs: (i) 8 control, 17 ADDwR, 17 
ADDwoR, and (ii) without OA (n = 25) and with OA (n = 17). The area of immunostaining was compared 
statistically between groups (P < 0.05). 
Results 
Statistically significant differences were found in the expression of FasL in TMJ discs between the three 
groups (P = 0.001). ADDwR presented significant higher FasL expression when compared with ADDwoR 
(P < 0.001). Significant higher FasL expression was observed in the group without OA (P = 0.001). All 
patients without OA presented ADDwR, while all the patients with OA presented ADDwoR. 
Conclusion 
A higher area of in situ immunostaining of FasL was found in temporomandibular discs with reduction, 
which is the less severe condition. Moreover, a reduced expression of FasL in the discs of patients with 
osteoarthrosis was found, suggesting that some aspects of apoptosis might underlie the progression of 
TMJ disorders. 
Introduction 
Disc derangement is defined as a malpositioning of the articular disc in relation to the condyle and 
eminence. The two most common types of internal derangement (ID) are anterior disc displacement 
with (ADDwR) and without (ADDwoR) reduction 1-4. 
Anterior disc displacement with reduction (ADDwR) is typically defined as a condition in which the 
articular disc of the temporomandibular joint (TMJ) is displaced while the mouth is closed and the teeth 
are in contact with maximal occlusion and slide into its normal functional position as the jaw open 5, 6. 
In ADDwoR, the condyle is unable to slide or snap back underneath the disc. The displaced disc thus 
does not reduce to its position on top of the condyle during the opening movement 5, 6. 
Clinically, TMJ with mild ID is characterized by disc displacement with or without osseous remodelling, 
while severe derangement includes disc or attachment perforations, osseous remodelling and 
osteoarthritic changes 7. 
Temporomandibular joint ID results from an imbalance between anabolic and catabolic processes, 
predominantly controlled by fibrochondrocytes, and is characterized by progressive degradation of the 
extracellular matrix of the articular disc 8-10. 
Disc displacement is associated with degenerative tissue changes, and it is considered to be a risk factor 
for osteoarthrosis (OA) development with abnormal remodelling of the condyle and mandibular fossa; 
however, the underlying mechanisms remain unclear 11-20. 
Under normal physiological conditions, a balance exists in synovial joints between tissue breakdown and 
repair. When the balance is disturbed by a biomechanical or inflammatory insult, the discal 
fibrocartilaginous remodelling system may fail, resulting in accelerated tissue breakdown 17. In TMJ 
diseases, the synovium and articular cartilage produce several mediators that have the potential to 
induce apoptosis 21. Discal fibrochondrocytes are the only cells that produce and maintain the disc 
extracellular matrix. Thus, changes in fibrochondrocyte survival (due to cell proliferation, apoptosis, and 
other forms of cell death) induced by endogenous mediators may be of pathogenic significance in the 
development of articular disc degradation 17, 18. 
Previous research has demonstrated a correlation between TMJ ID and apoptosis 22-28. Apoptosis is a 
physiopathological process implicated in various aspects of mammalian development, including 
embryogenesis, normal tissue turnover and homoeostasis, and also as a protection mechanism in 
immune reactions and diseases 22, 29. It can be triggered either by a mitochondrion-dependent intrinsic 
pathway or via a cell surface death receptor–mediated extrinsic pathway. Fas ligand (FasL, also called 
CD95L), tumour necrosis factor (TNF)‐α and TNF‐related apoptosis–inducing ligand (TRAIL) are common 
apoptosis-inducing factors, known to trigger apoptosis through distinct signal pathways 30, 29, 31-35. 
Fas ligand is a cell membrane–associated factor that induces apoptotic cell death and is related to 
various aspects of immune system, including cell-mediated cytotoxicity and self-tolerance. FasL seems 
to play an immunosuppressive role against not only itself but also exogenous antigens 36, 37. FasL has a 
pathogenic involvement in a variety of inflammatory diseases, including hepatitis, graft-versus-host 
diseases and pulmonary fibrosis 38-43. 
In this study, we tested the hypothesis that apoptosis may be involved in the progression of TMJ ID, as 
shown by previous research 22-28. Therefore, the present investigation was designed to evaluate, by 
immunohistochemistry, the expression of FasL in temporomandibular joint (TMJ) articular discs of 
patients with anterior disc displacement with (ADDwR) and without reduction (ADDwoR) in patients 
with and without osteoarthrosis (OA), focusing on the role, apoptosis may have in the association 
between severity of disc displacement and osteoarthrosis. 
Materials and methods 
Sample selection 
A sample of 42 temporomandibular discs from 29 patients (mean age 32.7 years old, range from 18 to 
56 years) was recruited for study from the patient pool at the Evangelico School Hospital, Curitiba, Brazil 
(Table 1), as approved by the Ethical Committee on Research at Pontifical Catholic University of Paraná, 
according to Resolution 196/96 of the National Health Council and approved under registration number 
104. The patients were from the southern region of Brazil. Subjects did not present any of the following 
criteria: use of orthodontic appliances; chronic usage of anti-inflammatory drugs; history of diabetes, 
hepatitis, HIV infection; immunosuppressive chemotherapy; history of any disease known to severely 
compromise immune function; current pregnancy or lactation; dentofacial deformity; major jaw trauma; 
previous TMJ surgery; and previous steroid injection in the TMJ. 
Table 1. Baseline clinical characteristics of the study group with and without TMJ dysfunction, associated 
with Wilkes Stage 
Affected 
side 









1 Caucasian F 39 ADDwoR X 
 
V With OA 
2 Caucasian M 27 CFx X 
  
Without OA 
3 Caucasian F 25 ADDwoR X 
 
V With OA 
4 Caucasian F 46 ADDwoR 
 
X V With OA 
4 Caucasian F 46 ADDwoR X 
 
V With OA 
5 Caucasian F 20 ADDwoR 
 
X V With OA 
5 Caucasian F 20 ADDwoR X 
 
V With OA 
6 Caucasian F 41 ADDwR 
 
X III Without OA 
6 Caucasian F 41 ADDwR X 
 
III Without OA 





8 Caucasian F 32 ADDwR 
 
X III Without OA 
8 Caucasian F 32 ADDwR X 
 
III Without OA 
9 Caucasian F 41 ADDwoR 
 
X V With OA 
9 Caucasian F 41 ADDwoR X 
 
V With OA 
10 Caucasian F 26 ADDwR 
 
X III Without OA 
10 Caucasian F 26 ADDwR X 
 
III Without OA 
11 Caucasian F 28 ADDwR 
 
X III Without OA 
11 Caucasian F 28 ADDwR X 
 
III Without OA 





13 Caucasian F 36 ADDwR 
 
X III Without OA 
13 Caucasian F 36 ADDwR X 
 
III Without OA 
14 Caucasian F 18 ADDwR 
 
X III Without OA 
14 Caucasian F 18 ADDwR X 
 
III Without OA 
15 Caucasian F 38 ADDwoR 
 
X IV With OA 
15 Caucasian F 38 ADDwoR X 
 
IV With OA 
16 Caucasian F 45 ADDwoR X 
 
IV With OA 





18 Caucasian F 51 ADDwoR 
 
X V With OA 
19 Caucasian F 33 ADDwoR X 
 
V With OA 
19 Caucasian F 33 ADDwoR 
 
X V With OA 
20 Caucasian M 22 CFx X 
  
Without OA 
21 Caucasian F 35 ADDwoR X 
 
IV With OA 
22 Caucasian F 22 ADDwR X 
 
III Without OA 
22 Caucasian F 22 ADDwR 
 
X III Without OA 
23 Caucasian F 24 ADDwR 
 
X III Without OA 
24 Caucasian M 18 CFx X 
  
Without OA 





26 Caucasian M 37 CFx X 
  
Without OA 
27 Caucasian F 23 ADDwoR X 
 
IV With OA 
27 Caucasian F 23 ADDwoR 
 
X IV With OA 
28 Caucasian F 42 ADDwR X 
 
III Without OA 
29 Caucasian F 56 ADDwR X 
 
III Without OA 
ADDwoR, anterior disc displacement without reduction; ADDwR, anterior disc displacement with 
reduction; CH, condyle hyperplasia; CFx, condyle fracture; OA, osteoarthrosis. 
 
Subjects completed personal medical history questionnaires and, within a protocol approved by an 
Institutional Review Board, signed a consent form after being advised of the nature of the study. 
All patients were asked to complete a pain questionnaire, and a clinical examination was performed by 
an experienced operating oral and maxillofacial surgeon. The clinical examination consisted of palpation 
of the TMJ region, the occurrence of painful opening/closing mouth, and crepitation. The patients were 
considered to be affected and treated surgically when presenting painful clinical signs of disc 
displacement after unsuccessful non-surgical treatment for at least 6 months. Regarding complementary 
exams, all patients had a panorex. These patients were from the Brazilian public health system; 
therefore, a few of them had financial conditions to afford other exams such as computerized 
tomography (CT) scan or a TMJ magnetic resonance imaging. Accordingly, the diagnoses were primarily 
clinical. 
Patients presenting disc displacement with and without reduction were grouped together for analysis. 
Out of the control patients, 4 individuals presented condyle fracture (CFx), confirmed by radiographs 
and CT scan, which needed to be operated for the fracture reduction and four subjects displayed active 
condyle hyperplasia (CH), diagnosed by radiographs, CT scan and scintigraphy, as follows: 
• Subjects without any signs of disc displacement (control group; n = 8; 8 specimens); 
• Patients presenting anterior disc displacement with reduction (ADDwR; n = 10; 17 specimens); 
• Patients presenting anterior disc displacement without reduction (ADDwoR; n = 11; 17 
specimens). 
 
Subjects were included in clinical categories according to the presence or absence of disc displacement 
and, at a second moment, according to the presence or absence of osteoarthrosis (using Wilkes 
classification) 44. 
Patients' selection for OA analysis was based on the primary diagnosis of severe TMJ ID. The stages of 
TMJ ID were classified into mild, intermediate and severe according to Wilkes classification based on 
clinical, surgical and pathological stages 44. Mild internal derangement (Wilkes stage III) is characterized 
by simple disc displacement without any morphological alteration of the disc and with or without 
osseous shift. The intermediate stage (Wilkes stage IV) is characterized by disc displacement and 
morphological deformity and/or osseous remodelling changes. Severe derangement (Wilkes stage V) is 
characterized by perforations of the disc attachments and osseous shift and/or osteoarthritic changes 
(sclerosis, osteophyte formation, articular surface flattening, depression and/or cystic alterations) 44. 
Patients from the control group and those classified as Wilkes III were considered not presenting OA 
and patients classified as Wilkes IV or V were included in the OA group, as follows: 
• Patients without OA (control group + Wilkes stage III; n = 18; 25 specimens). 
• Patient with OA (Wilkes stage IV and V; n = 11; 17 specimens). 
 
Table 1 shows the baseline characteristics of the sample. 
Surgical technique 
Temporomandibular joint surgery was performed according to the technique described by Mehra and 
Wolford 45. 
First, the displaced disc is freed by the surgeon entering the upper and lower joint spaces and lysing 
adhesions. At this point, a small hole is placed through the lateral pole of the condyle from posterior to 
anterior direction. The Mitek bone-cleat introducer is inserted and pushed into the bone, where two 
small coils unlock and attach the cleat to the inner surface of the condyle cortical bone. A non-
resorbable 2–0 or 3–0 suture is placed through the hole and through the disc at the junction of the 
posterior and intermediate bands, and the disc is tied down to the condylar neck. The deformity of the 
disc precludes repositioning it into a more normal position, and recontouring the thickened disc with a 
scalpel is necessary (this scalpelled material constitutes the sample). 
This procedure was conducted for all patients with disc displacement and the control group. In the CFx 
patients, the disc displaced by fracture was repositioned and in the CH patients, the disc was sutured to 
prevent disc displacement caused by the gap that was created after the high condylectomy. Post-
surgical physical therapy was indicated at the discretion of the surgeon. 
Histological sections obtained by scalpel of disc excess were prepared for observation of the in 
situ expression of FasL by immunohistochemistry. 
Immunohistochemistry 
The TMJ disc sections were deparaffinized with xylol (2 × 10 min) and rehydrated with absolute ethylic 
alcohol (3 × 1 min) and 80% ethylic alcohol (1 × 1 min). Endogenous peroxidase activity was quenched by 
treatment with H2O2 (5% in methanol) for 10 min. Target Retrieval Solution™ (Dako, DK-2600 Glostrup, 
Denmark) was used prior to slide staining for heat-inducing epitope retrieval (for formalin-fixed, 
paraffin-embedded material), according to the manufacturer's instructions. The sections were incubated 
with monoclonal FasL antibody (Novocastra, New Castle, UK), diluted 1:50 in phosphate-buffered saline 
(PBS), 0.1% bovine serum albumin (BSA). This monoclonal antibody immunostains only the cellular 
fraction of FasL. The soluble fraction (sFasL), which is an inhibitor of the ligation between FasL and Fas in 
the target cell, is not immunostained. For negative controls, the primary antibody was not added. PBS 
was used instead. The secondary antibody, Advance™ (Dako, DK-2600 Glostrup, Denmark), was applied 
for 30 min, according to the manufacturer's instruction. 
The immunoreactions were visualized by incubating the sections using 3,3′ diaminobenzidine (DAB) 
chromogen (OriGene, Rockville, MD), (1 drop in 1 mL distilled water). The sections were lightly 
counterstained with Harris haematoxylin for 5 min and finally mounted. Immunostaining was considered 
to be specific to FasL because immunoreactivity was not observed in the negative controls. 
The colour morphometry method was used to analyse the anti-FasL-immunostained area in the TMJ disc 
tissue. For this purpose, images of consecutive fields were captured by the 40× objective lens coupled 
with the BX50 Olympus microscope with the Sony camera, Model DXC-107A, and image analysis was 
performed with specific software called Image Pro Plus software (Media Cybernetics Inc., Silver Spring, 
USA). This software allows an observer to select and paint the positive areas to obtain an image model 
and make the mask for the other stained slides, being automatically calculated the area of the positive 
reaction (Fig. 1). This procedure was performed by a single examiner in a blind manner. The data were 
entered into a spread sheet, and Microsoft Excel (Redmond, WA, USA) was used to obtain the statistical 
analysis. The variable area was measured in square micrometers (μm2) and was obtained with the mean 
of all positive areas. 
 
Figure 1. (A) Microphotography showing the positive immunohistochemical reaction for Fas ligand in brown, used 
as the mask. (B) Image Pro Plus™ analysis of the positive immunohistochemical reaction identified by the software 
through a sample of brown coloration considered appropriated by the observer, pattern followed for all fields 




To compare the groups regarding the area, the model of analysis of variance with one factor (anova) 
was considered. To compare control and affected group, the Student's t-test for independent samples or 
nonparametric Mann–Whitney test was employed. To meet symmetrical condition of the variable, data 
of area are previously submitted to a logarithmic transformation. P value <0.05 was considered 
statistically significant. Data were analysed with the software Statistica V. 8.0 (StatSoft Inc., Tulsa, OK, 
USA). 
Results 
Fas ligand expression was observed at cytoplasmic membrane, especially in fibrochondrocytes, and 
statistically significant differences were found between TMJ samples of ADDwR and ADDwoR and 
between TMJ discs of patients with and without osteoarthrosis. 
Expression of FasL in TMJ sample ADDwR and ADDwoR 
Significant differences were found in the expression of FasL in TMJ discs between the three groups for 
the variable area (P = 0.001) (Table 2). However, it was observed significant difference only between 
ADDwR and ADDwoR groups (P < 0.001) (Table 3, Figs 2 and 3), with higher area of expression in the 
ADDwR (Table 2). 
Table 2. FasL area of immunostaining (μm2) in the discs of the study group with and without TMJ 
dysfunction 
Variable Group n Mean Median Minimum Maximum Standard deviation P-valuea 
Área Control 8 15.17 15.44 7.64 20.79 4.08 
 
 
ADDwR 17 22.91 19.85 11.21 45.68 11.50 0.001  
ADDwoR 17 12.26 10.85 5.97 20.65 4.43 
 
• a One-factor anova, P < 0.05. 
Table 3. Comparison 2 × 2 between groups with and without TMJ dysfunction with respect to area of 
expression (μm2) of FasL 
Groups P-valuea 
Control × ADDwR 0.062 
Control × ADDwoR 0.187 
ADDwR × ADDwoR <0.001 
• a Student's t-test for independent samples, P < 0.05. 
 
Figure 2. Immunostaining for Fas ligand in the temporomandibular joint disc of patients affected by disc 
displacement with reduction (ADDwR). (A) Magnification of 10×. Arrow = fibrochondrocyte. (B) Magnification of 
20×. Arrow = fibrochondrocyte. 
 
 
Figure 3. Immunostaining for Fas ligand in the temporomandibular joint disc of patients affected by disc 
displacement without reduction (ADDwoR). (A) Magnification of 10x. Arrow = fibrochondrocyte. (B) Magnification 
of 20×. Arrow = fibrochondrocyte. 
 
Expression of FasL in TMJ discs of patients with and without osteoarthrosis 
It was observed that all the patients with ADDwoR presented OA. On the other hand, all patients 
without OA presented ADDwR. 
Statistically significant differences were found in the expression of FasL in TMJ discs between the groups 
with and without OA for the variable area (P = 0.001) (Table 4). 
Table 4. Differences between groups with and without osteoarthrosis with respect to area of in 
situ expression (μm2) of FasL 








25 20.43 16.26 7.64 45.68 10.33 0.001a 
 
With osteoarthrosis 17 12.26 10.85 5.97 20.65 4.43 
 
• a Student's t-test for independent samples, P < 0.05. 
Discussion 
Increasingly, studies have shown that mechanism of apoptosis plays an important role in the 
progression of ID of the TMJ 22-28. 
In diseases of the TMJ, the synovium and articular cartilage produce various mediators, such as IL-1 and 
FasL, that have the potential to induce chondrocyte death through necrosis or apoptosis 46-48. Some 
studies showed correlation between TMJ ID and apoptosis mechanism. Imirzalioğlu et al. 28, in a study 
using synovial fluid through arthrocentesis from 17 joints in 17 patients found lower levels of sFas, 
suggesting vulnerability to apoptosis in patients with internal derangement. Increased levels of sFas 
blocked apoptosis by inhibiting binding of FasL to Fas on the cell membrane 28. Immunohistochemical 
studies with TMJ discs using some apoptosis markers found higher expression of caspase 3, TRAIL and 
DR5-positive cells in disc tissues in patients with ADDwR and ADDwoR than in control discs 22-27. 
In this study, the analysis of FasL in TMJ discs of patients with and without disc displacement showed an 
increased area of expression in fibrochondrocytes of the ADDwR group. Indeed, although physiologically 
FasL is expressed by some cells as T lymphocytes or natural killer (NK) cells 49, our study shows FasL 
expression by fibrochondrocytes. Biomechanical stress activates multiple parallel and converging signals 
for hypertrophy and apoptosis 50. Considering the physiopathology of disc displacement, the 
mechanical stress generated in jaw movement during the opening and closing of the mouth, which can 
be stimulated by sliding the disc into and out of its normal position, prompts the activation of apoptosis 
in these areas. Additionally, cartilage trauma may induce accelerated fibrochondrocyte apoptosis 50. 
Thus, the higher expression of the marker FasL (CD95L) found in cases of ADDwR compared with 
ADDwoR, in which a less intense inflammatory process and more mechanical stress may coexist, may 
induce the apoptosis process. This phenomenon can set up an endogenous reaction, which aims to 
restore homoeostasis and/or tissue remodelling. Therefore, the apoptotic event might work as a 
protective mechanism to overcome progression of disease. 
Osteoarthrosis is a focal degenerative disorder that primarily affects the articular cartilage and 
subchondral bone of synovial joints such as TMJ 51-53. It is a consensus that TMJ disc displacement and 
OA often occur concomitantly. The most frequently reported relationship is that disc displacement 
causes OA 17, 50, 52-60. With physiological loading, there is a balance between synthesis and 
breakdown within the tissue. When this adaptive capacity is exceeded, an inflammatory response may 
become clinically evident and may result in damage to the cells, leading to cell destruction. Thus, in OA, 
an inflammatory reaction reflects increased degenerative activity. 
In this study, we investigated a possible association of FasL expression in TMJ discs with osteoarthrosis 
process as the mechanism of apoptosis may influence the progression of ID. It was found an increase in 
the expression of FasL in TMJ discs of individuals without OA. It worth mentioning that in our study, we 
found a strong association between OA and ADDwoR, the most extreme phenotype, in which a greater 
inflammatory process and minor mechanical stress coexist. 
Our findings suggest that apoptosis process is a protective mechanism against TMJ disorder progression 
and reinforce that necrosis should be the main way of cell death in OA fibrochondrocytes 61. Moreover, 
considering that mechanical damage of articular cartilage is often associated with OA pathogenesis 61 
and that fibrochondrocyte necrosis occurs in damage of articular cartilage, we can suggest that 
apoptosis mechanism may precede necrosis on the TMJ ID. This might explain why there are some cases 
in which the progression from ADDwR to ADDwoR might not occur and cases of patients with OA who 
do not present TMJ problems. 
Future studies should be performed with a larger sample size, which may make it clear the association of 
a marker of apoptosis FasL with temporomandibular joint dysfunction. Although the sample number is 
small, to the authors' knowledge, it is the largest sample reported in literature. Besides, the sample was 
obtained from patients, and not from cadavers, as most study samples, which allows clinical 
examination and anamnesis. 
In conclusion, a higher expression of FasL was found in temporomandibular discs with reduction when 
compared with discs without reduction. Moreover, a lower expression of FasL in the discs of patients 
with osteoarthrosis was found, which suggests that apoptosis may protect against TMJ disorders 
progression. 
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